TEM ▼ -4.5% - Tempus AI, Inc. $TEM Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology Tempus AI shares declined 4.5% today despite the company securing up to $9.5 million in federal funding from ARPA-H's ADVOCATE program to deploy autonomous AI technology in cardiology. The grant represents validation of the company's clinical AI capabilities, though the modest funding amount relative to the company's market valuation may have disappointed investors expecting larger capital influxes to accelerate growth. 09-SEP-2026 04:02 PM ET